Intrinsic Medicine, Inc.
(Note: Intrinsic Medicine, Inc. withdrew its IPO plans in an SEC filing dated July 25, 2022. The preclinical therapeutics company had filed to go public on April 8, 2022.) We are a preclinical-stage therapeutics company leveraging synthetic biology-manufactured human identical milk oligosaccharide, or HiMO, molecules as new medicines to treat large patient populations underserved by […]
April 26, 2022 Read More